Anlon Healthcare

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
28.20
1.34 (4.99%)
BSENSE

Oct 09

BSE+NSE Vol: 2.34 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.34 cr (192.98%) Volume

Shareholding (Jun 2026)

FII

1.67%

Held by 6 FIIs

DII

1.22%

Held by 3 DIIs

Promoter

52.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 1,471 Cr ()

stock-summary
P/E

55.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

6.81

Revenue and Profits:
Net Sales:
88 Cr
(Quarterly Results - Jun 2026)
Net Profit:
7 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
82.64%
0%
82.64%
6 Months
131.34%
0%
131.34%
1 Year
122.22%
0%
122.22%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Board Meeting Intimation for Companys Business Expansion Plans In India And/Or Overseas And The Raising Of Funds/ Financing Thereof In One Or More Tranches

29-Sep-2026 | Source : BSE

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 inter alia to consider and approve to discuss and deliberate upon the Companys business expansion plans in India and/or overseas and the raising of funds/ financing thereof in one or more tranches through such permissible modes and means as the board of directors may deem fit including by way of equity debt hybrid instruments borrowings or any other mode or combination thereof subject to applicable regulatory and other approvals.

Closure of Trading Window

28-Sep-2026 | Source : BSE

We have attached herewith intimation as per SEBI (PIT) Regulations 2015.

Intimation Of Participation In Arihant Capital BHARAT CONNECT CONFERENCE RISING STARS 2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

24-Sep-2026 | Source : BSE

We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation 2015.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

13 Oct 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

stock-summary
BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
30.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.89%
ROCE (avg)
9.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
55
Industry P/E
36
Price to Book Value
6.81
EV to EBIT
32.10
EV to EBITDA
31.02
EV to Capital Employed
5.83
EV to Sales
8.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.78%
ROE (Latest)
13.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
No Trend
OBV
Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 6 FIIs (1.67%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

26.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -44.10% vs 55.76% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -50.97% vs 90.10% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.98",
          "val2": "55.42",
          "chgp": "-44.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.47",
          "val2": "13.91",
          "chgp": "-46.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.96",
          "val2": "1.18",
          "chgp": "-18.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.80",
          "val2": "9.79",
          "chgp": "-50.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.11%",
          "val2": "25.10%",
          "chgp": "-0.99%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Anlon Healthcare"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Anlon Healthcare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary
Jun'26
Mar'26
Change(%)
Net Sales
30.98
55.42
-44.10%
Operating Profit (PBDIT) excl Other Income
7.47
13.91
-46.30%
Interest
0.96
1.18
-18.64%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.80
9.79
-50.97%
Operating Profit Margin (Excl OI)
24.11%
25.10%
-0.99%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -44.10% vs 55.76% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -50.97% vs 90.10% in Mar 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
176.50
120.29
46.73%
Operating Profit (PBDIT) excl Other Income
46.14
32.21
43.25%
Interest
4.35
3.72
16.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
27.81
20.52
35.53%
Operating Profit Margin (Excl OI)
26.14%
26.78%
-0.64%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details